Literature DB >> 2475759

Glycine regulation of the N-methyl-D-aspartate receptor-gated ion channel in hippocampal membranes.

D W Bonhaus1, G C Yeh, L Skaryak, J O McNamara.   

Abstract

The N-methyl-D-aspartate receptor-gated ion channel (NMDA channel) is regulated by glycine. To examine the interaction of glycine and NMDA receptor ligands on NMDA channel function, we used a biochemical marker of channel opening, [3H]N-(1-[thienyl]cyclohexyl)piperidine (TCP). We quantified [3H]glycine,L-[3H]glutamate, and TCP binding in an identical membrane preparation. This allowed direct comparison of NMDA and glycine receptor occupancy and channel activation. Glycine increased the association and dissociation rates of NMDA-dependent TCP binding to hippocampal membranes, without altering the Kd or Bmax for TCP binding. Structurally similar amino acids mimicked the action of glycine, with D-isomers being more potent than L-isomers. The potency of glycine in regulating TCP binding matched that for displacing [3H]glycine. Glycine stimulation of TCP binding required the presence of NMDA agonists and was inhibited by the NMDA antagonist D-2-amino-5-phosphonovaleric acid. Glycine stimulation of NMDA-dependent TCP binding was not associated with an increase in agonist binding to the NMDA receptor. Likewise, NMDA stimulation of glycine-dependent TCP binding was not associated with an increase in the binding of glycine to the glycine receptor. These findings permit the following conclusions: 1) glycine stimulates TCP binding solely by increasing the access of TCP to its site in the NMDA channel; 2) TCP binding can be used to quantify glycine regulation of the NMDA channel; 3) a stereospecific glycine receptor, as part of the NMDA receptor-channel complex, regulates NMDA-evoked channel opening by a mechanism not involving increased agonist binding to the NMDA receptor. Thus, it appears that the mechanism of glycine and NMDA receptor regulation of the NMDA channel is analogous to that of a two-key lock; both receptors, by independent and mutually required mechanisms, alter channel conformation to allow ion passage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475759

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones.

Authors:  M Benveniste; J Clements; L Vyklický; M L Mayer
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

2.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

3.  Sodium-dependent release of exogenous glycine from preloaded rat hippocampal synaptosomes.

Authors:  A Galli; F Mori; M Bargellini; L Coppini
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain.

Authors:  S W D'Souza; S E McConnell; P Slater; A J Barson
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

5.  Two types of steady-state desensitization of N-methyl-D-aspartate receptor in isolated hippocampal neurones of rat.

Authors:  I V Chizhmakov; N I Kiskin; O A Krishtal
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

6.  Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neurons.

Authors:  J W Johnson; P Ascher
Journal:  J Physiol       Date:  1992-09       Impact factor: 5.182

Review 7.  Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes.

Authors:  Wenbo Xu; Xiaoxiao Yao; Fangyi Zhao; Haisheng Zhao; Ziqian Cheng; Wei Yang; Ranji Cui; Songbai Xu; Bingjin Li
Journal:  Neural Plast       Date:  2020-11-26       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.